Amblyopia treatment studies

Current Opinion in Ophthalmology

Volumn 15, Issue 5, 2004, Pages 432-436

  Bacal, Darron A ^a,b  

^a Eye Physicians and Surgeons   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Amblyopia; Atropine; Levodopa; Occlusion therapy

Indexed keywords

ATROPINE; LEVODOPA;

ADOLESCENT; AMBLYOPIA; ANISOMETROPIA; BLOOD BRAIN BARRIER; CHILD; CLINICAL PRACTICE; CLINICAL RESEARCH; DEVICE; DRUG EFFECT; DRUG EFFICACY; EYE PATCHING; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; VISUAL ACUITY;

AMBLYOPIA; ATROPINE; HUMANS; PARASYMPATHOLYTICS; SENSORY DEPRIVATION;

EID: 4644318244     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.icu.0000137853.99831.3d     Document Type: Review

References (51)

1. Flynn JT: Amblyopia revisited. J POS 1991, 28:183-201.
2. Kaye SB, Chen SI, Price G, et al.: Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia. J AAPOS 2002, 6:289-293.
3. Roberts CJ, Adams GG: Contact lenses in the management of high anisometropic amblyopia. Eye 2002, 16:577-579.
4. Autrata R, Rehurek J: Laser-assisted subepithelial keratectomy and photoretractive keratectomy versus conventional treatment of myopic anisometropic amblyopia in children. J Cataract Refract Surg 2004, 30:74-84. Discusses the use of refractive surgery in high myopic anisometropes who were contact lens intolerant.
5. Wisel TN: Postnatal development of the visual cortex and the influence of the environment. Nature 1982, 299:582-591.
6. Snowdon S, Stewart-Brown S: Preschool vision screening: results of a systematic review. York: NHS Centre for Reviews and Dissemination, University of York, 1997. CRD Report 9.
7. Williams C, Northstone K, Harrad RA, et al.: Amblyopia treatment outcomes after screening before or at age 3 years: followup from randomized trial. BMJ 2002, 324:1549-1551.
8. Williams C, Northstone K, Harrad RA, et al.: Amblyopia treatment outcomes after preschool screening vs school entry screening: observational data from a prospective cohort study. Br J Ophthalmol 2003, 87:988-993.
9. Membreno JH, Brown MM, Brown GC, et al.: A cost-utility analysis of therapy for amblyopia. Ophthalmology 2002, 109:2265-2271.
10. Rahi JS, Logan S, Borja MC, et al.: Prediction of improved vision in the amblyopic eye after visual loss in the non-amblyopic eye. Lancet 2002, 360:621-622.
11. Beck RW: Clinical research in pediatric ophthalmology: the Pediatric Eye Disease Investigator Group. Curr Opin Ophthalmol 2002, 13:337-340.
12. Holmes JM, Beck RW, Repka MX, et al.: The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol 2003, 119:1345-1353.
13. Felius J, Wang YZ, Birch EE: The accuracy of the amblyopia treatment study visual acuity testing protocol. J AAPOS 2003, 7:406-412. Computer simulations were used to determine the accuracy of the amblyopia treatment study visual acuity protocol for 3- to 6-year-old children.
14. Rice ML, Leske DA, Holmes JM: Comparison of the amblyopia treatment study HOTV and electronic-early treatment of diabetic retinopathy study visual acuity protocols in children aged 5 to 12 years. Am J Ophthalmol 2004, 137:278-282.
15. Cole SR, Beck RW, Moke PS, et al.: The amblyopia treatment index. J AAPOS 2001, 5:250-254.
16. Woodruff G, Hiscox F, Thompson JR, et al.: Factors affecting the outcome of children treated for amblyopia. Eye 1994, 8:627-631.
17. Chua BE, Johnson K, Martin F: A retrospective review of the associations between amblyopia type, patient age, treatment compliance and referral patterns. Clin Exp Ophthalmol 2004, 32:175-179.
18. Searle A, Norman P, Harrad R, Vedhara K: Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children. Eye 2002, 16:150-155.
19. Newsham D: A randomized controlled trial of written information: the effect on parental non-concordance with occlusion therapy. Br J Ophthalmol 2002, 86:787-791.
20. Norman P, Searle A, Harrad R, et al.: Predicting adherence to eye patching in children with amblyopia: an application of protection motivation theory. Br J Health Psychol 2003, 8:67-82.
21. Simons K, Gotzler KC, Vitale S: Penalization vs part-time occlusion and binocular outcome in treatment of strabismic amblyopia. Ophthalmology 1997, 104:2156-2160.
22. Foley-Nolan A, McCann A, O'Keefe M: Atropine penalization vs occlusion as the primary treatment for amblyopia. Br J Ophthalmol 1997, 81:54-57.
23. Pediatric Eye Disease Investigator Group: A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002, 120:268-278.
24. Pediatric Eye Disease Investigator Group: The clinical profile of moderate amblyopia in children younger than 7 years. Arch Ophthalmol 2002, 120:281-287.
25. Pediatric Eye Disease Investigator Group: A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors. Ophthalmology 2003, 110:1632-1637. Further breaks down the data from ATS 1 and studies the role of a heavier patching regimen in patients with dense amblyopia.
26. Pediatric Eye Disease Investigator Group: The course of moderate amblyopia treated with patching in children: experience of the amblyopia treatment study. Am J Ophthalmol 2003, 136:620-629. Breaks down data from ATS 1 regarding the patching arm of the study.
27. Wright KW, Guyton DL: A test for predicting the effectiveness of penalization on amblyopia. Acta XXIV International Congress of Ophthalmology. Philadelphia: JB Lippincott, 1983.
28. Pediatric Eye Disease Investigator Group: The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study. Am J Ophthalmol 2003, 136:630-639. Breaks down data from ATS 1 regarding the atropine arm of the study.
29. Pediatric Eye Disease Investigator Group: Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol 2003, 121:1625-1632. Looks at the findings of the Amblyopia Treatment Index questionnaire.
30. Choong YF, Lukman H, Martin S, et al.: Childhood amblyopia treatment: psychosocial implications for patients and primary carers. Eye 2004, 18:369-375.
31. Kushner BJ: Atropine vs. patching for the treatment of moderate amblyopia in children. Arch Ophthalmol 2002, 120:387-388.
32. Pediatric Eye Disease Investigator Group: A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 2003, 110:2075-2087. Examines the effectiveness of part-time versus full-time patching in the treatment of severe amblyopia and discusses this in detail.
33. Pediatric Eye Disease Investigator Group: A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 2003, 121:603-611. Examines different prescribed patching regimens in the treatment of moderate amblyopia and discusses this in detail.
34. Fielder AR, Irwin M, Auld R, et al.: Compliance in amblyopia therapy: objective monitoring of occlusion. Br J Ophthalmol 1995, 79:585-589.
35. Simonsz HJ, Polling JR, Voorn R, et al.: Electronic monitoring of treatment compliance in patching for amblyopia. Strabismus 1999, 17:113-123.
36. Stewart CE, Fielder AR, Stephens DA, et al.: Design of the monitored occlusion treatment of amblyopia study (MOTAS). Br J Ophthalmol 2002, 86:296-299.
37. Leguire LE, Rogers GL, Walson PD, et al.: Occlusion and levodopacarbidopa treatment for childhood amblyopia. J AAPOS 1998, 2:257-264.
38. Leguire LE, Walson PD, Rogers GL, et al.: Levodopa/carbidopa treatment for amblyopia in older children. J Pediatr Ophthalmol Strabismus 1995, 32:143-151.
39. Pandey PK, Chaudhuri Z, Kumar M, et al.: Effect of levodopa and carbidopa in human amblyopia. J Pediatr Ophthalmol Strabismus 2002, 39:81-89.
40. Leguire LE, Komaromy KL, Nairus TM, et al.: Long-term follow-up of L-dopa treatment in children with amblyopia. J Pediatr Ophthalmol Strabismus 2002, 39:326-330.
41. Yang CI, Yang ML, Huang JC, et al.: Functional MRI of amblyopia before and after levodopa. Neurosci Lett 2003, 339:49-52.
42. Bhartiya P, Sharma P, Biswas NR, et al.: Levodopa-carbidopa with occlusion in older children with amblyopia. J AAPOS 2002, 6:368-372.
43. Stewart CE, Moseley MJ, Fielder AR: Defining and measuring treatment outcome in unilateral amblyopia. Br J Ophthalmol 2003, 87:1229-1231.
44. FitzGerald DE, Krumholtz I: Maintenance of improvement gains in refractive amblyopia: a comparison of treatment modalities. Optometry 2002, 73:153-159.
45. Clarke MP, Wright CM, Hrisos S, et al.: Randomised controlled trial of treatment of unilateral visual impairment detected at preschool vision screening. BMJ 2003, 327:1251-1256.
46. Lee SY, Isenberg SJ: The relationship between stereopsis and visual acuity after occlusion therapy for amblyopia. Ophthalmology 2003, 110:2088-2092. This paper looks at the relationship between improvement of stereopsis and visual acuity in anisometropic and small or intermittent angle strabismic amblyopes.
47. Rahi J, Logan S, Timms C, et al.: Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population-based study. Lancet 2002, 360:597-602.
48. Ohlsson J, Baumann M, Sjostrand J, et al.: Long term visual outcome in amblyopia treatment. Br J Ophthalmol 2002, 86:1148-1151.
49. Pediatric Eye Disease Investigator Group: A prospective pilot study of treatment of amblyopia in children 10 to <18 years old. Am J Ophthalmol 2004, 137:581-583. A pilot study of amblyopia treatment in older children.
50. Mohan KM, Saroha V, Sharma A: Successful occlusion therapy for amblyopia in 11- to 15-year-old children. J Pediatr Ophthalmol Strabismus 2004, 41:89-95. Looks at the ability to improve amblyopia in older children with full-time patching.
51. Moseley MJ, Neufeld M, McCarry B, et al.: Remediation of refractive amblyopia by optical correction alone. Ophthalmic Physiol Opt 2002,22:296-299.